A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer

BACKGROUND: This single‐arm prospective phase II trial was performed to assess the efficacy and safety of the dual oral metronomic vinorelbine and capecitabine (mNC) regimen in women with HER2‐negative metastatic breast cancer (MBC) in China. METHODS: The mNC regimen was administered to the enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Yue, Liu, Jiaxuan, Jiang, Mingxia, He, Maiyue, Wang, Zijing, Ma, Fei, Wang, Jiayu, Yuan, Peng, Luo, Yang, Xu, Binghe, Li, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423658/
https://www.ncbi.nlm.nih.gov/pubmed/37402471
http://dx.doi.org/10.1111/1759-7714.15011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423658/
https://www.ncbi.nlm.nih.gov/pubmed/37402471
http://dx.doi.org/10.1111/1759-7714.15011

Ejemplares similares